Skip to main content

Table 2 Evaluation of tumor size before and after paclitaxel/carboplatin chemotherapy using CT scans

From: Investigating the clinical potential for 14-3-3 zeta protein to serve as a biomarker for epithelial ovarian cancer

Patient no.

SLD of target lesions 10 (+/− 4) d before chemotherapy (mm)

SLD of target lesions 10 (+/− 4) d after the last cycle of chemotherapy (mm)

Non-target lesion changes*

1

22

0

−1

2

56

0

−1

3

84

0

−1

4

0

0

0

5

137

0

−4

6

0

0

0

7

0

0

0

8

441

202

−1

9

256

18

−3

10

147

0

−3

11

125

0

−1

12

46

18

−1

13

39

14

−3

  1. SLD: sum of length diameter; according to RECIST 1.1 guidelines.
  2. *Negative values represent a decrease in lesion size.